Mohammed El-Behairy

Dr. Mohammed El-Behairy

Faculty of Pharmacy, University of Sadat City
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMohamed Aboul-Enein
Mohamed Aboul-Enein
AEAida El-Azzouny
Aida El-Azzouny
MAMohamad Attia
Mohamad Attia
YMYousreya A. Maklad
Yousreya A. Maklad
KAKamilia M. Amin
Kamilia M. Amin
MEMohammed El-Behairy
Mohammed El-Behairy


12 July 2023 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MAMohammad Alsanea
Mohammad Alsanea
MAMohammed S AbdelMaksoud
Mohammed S AbdelMaksoud
MEMohammed El-Behairy
Mohammed El-Behairy
AAAbdelrahman Hamdi Abdelkhalek
Abdelrahman Hamdi Abdelkhalek
HRHidayat Ur Rahman
Hidayat Ur Rahman
ASAhmed AbuBakr Mohamed Salem
Ahmed AbuBakr Mohamed Salem

1 October 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
RHRasha M. Hassan
Rasha M. Hassan
MAMona E. Aboutabl
Mona E. Aboutabl
Manuela BozziManuela Bozzi
Manuela Bozzi
MEMohammed El-Behairy
Mohammed El-Behairy
AKAhmed M. El Kerdawy
Ahmed M. El Kerdawy
IGIman Ghannam
Iman Ghannam

1 March 2023 in ChemMedChem
Verified
Journal Article
Open access
EAEman M. Alghamdi
Eman M. Alghamdi
ZAZahra M. Alamshany
Zahra M. Alamshany
MHMohamed A. El Hamd
Mohamed A. El Hamd
EAEHAB SAADELDIN ALANWAR
EHAB SAADELDIN ALANWAR
MEMohammed El-Behairy
Mohammed El-Behairy
AMAdel Marzouk
Adel Marzouk
A new series of tetrasubstituted imidazole derivatives carrying pyrimidine sulfonamide pharmacophores has been synthesized and evaluated for their anticancer activities. In‐vitro screening of these hybrids against a full 60‐cell‐line panel at a single dose of 10 μM showed significant growth inhibition of up to 95 %. The most active compound showed in‐vitro anticancer activities against (i) abnormal HER2 and (ii) two mutants for EGFR. Apoptotic gene expression revealed that lead compounds induced MCF‐7 cell line apoptosis together with considerable change in the Bax/Bcl‐2 expression ratio. One lead compound led to a significant cell‐cycle S‐phase arrest, while another blocked the cell cycle at G1/S‐phase causing the accumulation of cells. Docking analysis of these two hybrids adopted the orientation and binding interactions with a higher liability to enter the active side pocket of HER2, L858R, and T790 M, preferable to that of co‐crystallized ligands. Modelling simulation was consistent with the acquired biological evaluation.

25 February 2021 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
MFMarwa A.A. Fayed
Marwa A.A. Fayed
MEMohammed El-Behairy
Mohammed El-Behairy
IAInas Abdallah
Inas Abdallah
HAHend Mohamed Abdel-Bar
Hend Mohamed Abdel-Bar
Hanan ElimamHanan Elimam
Hanan Elimam
YEYaseen Elshaier
Yaseen Elshaier
This work was a structured virtual screening for marine bioactive compounds with reported antiviral activities which were subjected to structure-based studies against SARS-CoV-2 co-crystallized proteins. The molecular docking of marine bioactive compounds against the main protease (Mpro, PDB ID: 6lu7 and 6y2f), the spike glycoprotein (PDB ID: 6vsb), and the RNA polymerase (PDB ID: 6m71) of SARS-CoV-2 was performed. Ligand-based approach with the inclusion of rapid overlay chemical structures (ROCS) was also addressed in order to examine the probability of these marine compounds sharing relevance and druggability with the reported drugs. Among the examined marine library, the highest scores in different virtual screening aspects were displayed by compounds with flavonoids core, acyl indole, and pyrrole carboxamide alkaloids. Moreover, a complete overlay with the co-crystallized ligands of Mpro was revealed by sceptrin and debromo-sceptrin. Thalassoilin (A-B) which was found in the Red Sea exhibited the highest binding and similarity outcomes among all target proteins. These data highlight the importance of marine natural metabolites in regard to further studies for discovering new drugs to combat the COVID-19 pandemic.